Efficacy and Safety of Paliperidone Palmitate 6-Month versus Paliperidone Palmitate 3-Month Long-Acting Injectable in European Patients with Schizophrenia: A Post Hoc Analysis of a Global Phase-3 Double-Blind Randomized Non-Inferiority Study.
暂无分享,去创建一个
M. Pompili | S. Gopal | M. García-Portilla | U. Richarz | Arun Singh | R. K. Knight | José Antunes | Cesar Giron-Hernandez | Joong Hee Han | R. Alberio